- Investor's Business Daily•17 hours ago
Vertex investors will key in for more data on cystic fibrosis drugs late Wednesday when the No. 6 biotech by market cap is set to report first-quarter earnings.
- Investopedia•21 hours ago
The biotech sector is gaining ground after strong first quarter earnings and could finally be headed into a major recovery.
- Zacks•23 hours ago
Nivalis Therapeutics, Inc. (NVLS) is expected to report first-quarter 2017 results early next month. Last quarter, the company had a positive surprise of 9.09%.
VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance
Vertex Pharmaceuticals Incorpor (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||116.00 x 1000|
|Ask||117.00 x 100|
|Day's Range||116.07 - 118.08|
|52 Week Range||71.46 - 118.79|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-252.91|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|